CD4(+) regulatory T cells - PubMed (original) (raw)
Review
CD4(+) regulatory T cells
S Read et al. Curr Opin Immunol. 2001 Dec.
Abstract
There is now compelling evidence that CD4(+) T cells that specialize in the suppression of immune responses play a key role in the control of immune pathology. Recently, there have been a number of reports that have provided information on the generation of CD4(+) regulatory T cells in the thymus and in the periphery. These cells have also been identified in humans, paving the way for analysis of the function of CD4(+) regulatory T cells in immune-mediated disease.
Similar articles
- Regulatory T cells in the control of immune pathology.
Maloy KJ, Powrie F. Maloy KJ, et al. Nat Immunol. 2001 Sep;2(9):816-22. doi: 10.1038/ni0901-816. Nat Immunol. 2001. PMID: 11526392 Review. - Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance.
Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S. Itoh M, et al. J Immunol. 1999 May 1;162(9):5317-26. J Immunol. 1999. PMID: 10228007 - The role of self-peptides in the development of CD4+ CD25+ regulatory T cells.
Picca CC, Caton AJ. Picca CC, et al. Curr Opin Immunol. 2005 Apr;17(2):131-6. doi: 10.1016/j.coi.2005.01.003. Curr Opin Immunol. 2005. PMID: 15766671 Review. - Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance.
Taams L, Vukmanovic-Stejic M, Salmon M, Akbar A. Taams L, et al. Transpl Immunol. 2003 Jul-Sep;11(3-4):277-85. doi: 10.1016/S0966-3274(03)00047-9. Transpl Immunol. 2003. PMID: 12967781 Review. - CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice.
Nishioka T, Shimizu J, Iida R, Yamazaki S, Sakaguchi S. Nishioka T, et al. J Immunol. 2006 Jun 1;176(11):6586-93. doi: 10.4049/jimmunol.176.11.6586. J Immunol. 2006. PMID: 16709816
Cited by
- Controversies concerning thymus-derived regulatory T cells: fundamental issues and a new perspective.
Ono M, Tanaka RJ. Ono M, et al. Immunol Cell Biol. 2016 Jan;94(1):3-10. doi: 10.1038/icb.2015.65. Epub 2015 Jul 28. Immunol Cell Biol. 2016. PMID: 26215792 Free PMC article. - Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells.
Lopez-Pastrana J, Shao Y, Chernaya V, Wang H, Yang XF. Lopez-Pastrana J, et al. Transl Res. 2015 Jan;165(1):221-40. doi: 10.1016/j.trsl.2014.08.001. Epub 2014 Aug 15. Transl Res. 2015. PMID: 25193380 Free PMC article. Review. - Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines.
Johnson EL, Chakraborty R. Johnson EL, et al. Retrovirology. 2012 Dec 5;9:101. doi: 10.1186/1742-4690-9-101. Retrovirology. 2012. PMID: 23217137 Free PMC article. - Immunosuppressive effect of regulatory T lymphocytes in lung cancer, with special reference to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes.
Shigematsu Y, Hanagiri T, Shiota H, Kuroda K, Baba T, Ichiki Y, Yasuda M, Uramoto H, Takenoyama M, Yasumoto K, Tanaka F. Shigematsu Y, et al. Oncol Lett. 2012 Oct;4(4):625-630. doi: 10.3892/ol.2012.815. Epub 2012 Jul 20. Oncol Lett. 2012. PMID: 23205074 Free PMC article. - Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models.
Shen L, Ciesielski M, Ramakrishnan S, Miles KM, Ellis L, Sotomayor P, Shrikant P, Fenstermaker R, Pili R. Shen L, et al. PLoS One. 2012;7(1):e30815. doi: 10.1371/journal.pone.0030815. Epub 2012 Jan 27. PLoS One. 2012. PMID: 22303460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials